Excelra

Excelra Excelra's data and analytics solutions empower innovation in life sciences across the value chain from discovery to market.

The Excelra Edge comes from a seamless amalgamation of proprietary curated data assets, deep domain expertise and data science. The company's multifaceted teams harmonize and analyze large volumes of disparate unstructured data using cutting-edge technologies. We galvanize data-driven decisions to unlock operational efficiencies to accelerate drug discovery and development. Over the past 18 years, Excelra has been the preferred data and analytics partner to over 90 global clients including 15 of the top 20 large Pharma companies.

Meet our experts at Lab of the Future USA 2026!Schedule a meeting: https://na2.hubs.ly/H03XNR70 Join us at Booth  #21 to...
26/02/2026

Meet our experts at Lab of the Future USA 2026!
Schedule a meeting: https://na2.hubs.ly/H03XNR70

Join us at Booth #21 to explore how Scientific and Lab Informatics, through LIMS, ELN, and SDMS integration, scalable architectures, and unified experimental can transform fragmented lab systems into connected, efficient, and insight driven ecosystems.

Let’s discuss how to future-proof your laboratory operations and accelerate R&D with confidence.

1 Day to Go!Last Chance to Register: https://na2.hubs.ly/H03VYWz0AI ambition is everywhere in biopharma. Ex*****on is no...
25/02/2026

1 Day to Go!
Last Chance to Register: https://na2.hubs.ly/H03VYWz0

AI ambition is everywhere in biopharma. Ex*****on is not.
Join us tomorrow, Feb 26, 2026 for Making Biopharma AI-Ready, a candid fireside chat with John Overington (Drug Hunter) in conversation with Excelra’s Radha Thammineni and Lavinia Woodward.

From overlooked data gaps to the quiet risks that derail AI programs, this discussion cuts through the noise and focuses on what truly drives impact.

If AI is part of your 2026 strategy, this is a conversation you shouldn’t miss.

&D

  | How do you decode a target’s role in the tumor microenvironment without knockout models? Explore the full case study...
24/02/2026

| How do you decode a target’s role in the tumor microenvironment without knockout models? Explore the full case study: https://na2.hubs.ly/H03TqsT0

By combining spatial transcriptomics, scRNA-seq analysis, correlation mapping, and a novel ROI-based comparative approach, we uncovered immune associations, differential gene expression patterns, and cytokine-level insights across multiple cancer contexts.

Read the full case study to see how spatially resolved analytics accelerates precision oncology decision-making.

We’re proud to be speaking at Precision Medicine Conference 2026!Join Lavinia Woodward, Director – Client Advisory & Con...
23/02/2026

We’re proud to be speaking at Precision Medicine Conference 2026!
Join Lavinia Woodward, Director – Client Advisory & Consulting, on 6th Mar | 11:30 AM, for a thought-provoking session: “Linking Biology and Chemistry: Integrating Transcriptomics with Structure–Activity Relationships”

Structurally similar compounds often trigger very different cellular responses, highlighting the need for deeper, mechanism-driven insight. In this session, Lavinia will show how generative AI seamlessly integrates transcriptomic perturbation data with curated SAR intelligence to uncover hidden biological connections, enabling sharper target understanding and more confident compound prioritization.

We look forward to engaging with leaders advancing the future of precision medicine and data-driven drug discovery.

We’re thrilled to be exhibiting at Lab of the Future USA 2026. Stop by Booth  #21 to discover how Excelra is advancing S...
20/02/2026

We’re thrilled to be exhibiting at Lab of the Future USA 2026.

Stop by Booth #21 to discover how Excelra is advancing Scientific Informatics to create connected, intelligent, and insight-driven laboratory ecosystems. By unifying experimental and operational data and enabling scalable informatics frameworks, we help organizations modernize lab environments and accelerate innovation with confidence.

Let’s connect and build the next generation of future-ready laboratories.

1 Week to Go!Register Now: https://na2.hubs.ly/H03NQZ70 Every biopharma company has an AI strategy. Far fewer have the d...
19/02/2026

1 Week to Go!
Register Now: https://na2.hubs.ly/H03NQZ70

Every biopharma company has an AI strategy. Far fewer have the data foundations to execute one. Join us on Feb 26, 2026 for Making Biopharma AI-Ready: A Fireside Chat with John Overington (Drug Hunter) in conversation with Excelra’s Radha Thammineni and Lavinia Woodward.

From hidden LLM traps to what “good” AI-ready data really looks like, gain candid insights on what works, what fails, and where to focus first. Don’t miss this practical, discussion on turning AI ambition into real ex*****on.

&D

  | How do you extract actionable tumor insights from contaminated PDX RNA-seq data? Explore the full case study: https:...
18/02/2026

| How do you extract actionable tumor insights from contaminated PDX RNA-seq data? Explore the full case study: https://na2.hubs.ly/H03KLRw0

By combining demousing, advanced QC, DEG analysis, pathway enrichment, and survival integration into a scalable RNA-seq pipeline, enabling faster biomarker discovery and translational oncology impact.

Read the full case study to see how precision analytics accelerates precision medicine.

  | How do you identify tumor-enriched, lineage-specific targets with clinical relevance? Discover how it was achieved: ...
17/02/2026

| How do you identify tumor-enriched, lineage-specific targets with clinical relevance? Discover how it was achieved: https://na2.hubs.ly/H03KLC60

By integrating TCGA & GEO datasets with bulk and scRNA-seq analysis, Excelra built a structured bioinformatics workflow to perform tumor enrichment, lineage filtering, and multi-database gene annotation for SCLC and o***y carcinoma.

This case study highlights how scalable transcriptomic pipelines and curated gene prioritization frameworks enable confident target discovery for precision oncology research.

We’re proud to be a Sponsor at Lab of the Future USA 2026. Meet us at Booth  #21 to explore how Excelra is enabling conn...
16/02/2026

We’re proud to be a Sponsor at Lab of the Future USA 2026.

Meet us at Booth #21 to explore how Excelra is enabling connected, intelligent, and data-driven laboratories through advanced Scientific Informatics.

From harmonizing experimental and operational data to building scalable informatics ecosystems, we’re helping organizations move from fragmented workflows to future-ready research environments.

Meet our experts at SapioCon 2026!Schedule a meeting: https://na2.hubs.ly/H03zxHr0 Join us in Boston, USA, on February 1...
13/02/2026

Meet our experts at SapioCon 2026!
Schedule a meeting: https://na2.hubs.ly/H03zxHr0

Join us in Boston, USA, on February 18–19, 2026, and discover how Excelra’s Lab Informatics and Scientific Informatics solutions are helping life sciences organizations build digitally connected, efficient, and compliant laboratories.

Connect with our experts to explore LIMS, ELN, and SDMS integration, scalable informatics architectures, and data-driven strategies that streamline laboratory workflows and accelerate R&D.

Is your biopharma AI-ready or just AI-aware?Register for our Fireside Chat: https://na2.hubs.ly/H03zwgc0 Many AI initiat...
12/02/2026

Is your biopharma AI-ready or just AI-aware?
Register for our Fireside Chat: https://na2.hubs.ly/H03zwgc0

Many AI initiatives stall not because of models, but because the data isn’t ready.

Join our exclusive Fireside chat: Making Biopharma AI-Ready with John Overington (Head of Data, Drug Hunter) in conversation with Radha Thammineni and Lavinia Woodward from Excelra to explore what works, what fails, and the hidden traps holding AI back.

Date: 26 Feb 2026
Time: 15:00 UK | 10:00 ET | 07:00 PT

  | How do you scale multi-omic cancer data without losing reproducibility?Discover how it was achieved: https://na2.hub...
11/02/2026

| How do you scale multi-omic cancer data without losing reproducibility?
Discover how it was achieved: https://na2.hubs.ly/H03zwKK0

By building modular, production-ready bioinformatics pipelines for RNA-Seq, scRNA-Seq, WGS/WES, HLA typing, and SAREK using Nextflow and Docker, Excelra transformed complex oncology datasets into scalable, fault-tolerant workflows with optimized performance and robust QC.

This case study shows how cloud-ready bioinformatics automation helps computational oncology teams accelerate genomic analysis and biomarker discovery.

Address

7th Floor Wing B
Uppal
500039

Opening Hours

Monday 9am - 6pm
Tuesday 9am - 6pm
Wednesday 9am - 6pm
Thursday 9am - 6pm
Friday 9am - 6pm

Telephone

+91 40 6707 3333

Alerts

Be the first to know and let us send you an email when Excelra posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Excelra:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram